Stock Market Reviews

TMCI (Treace Medical Concepts, Inc.) News

Get the latest news, insights, and market updates on TMCI (Treace Medical Concepts, Inc.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Treace Medical Concepts (TMCI) Reports Q3 Loss, Beats Revenue Estimates
  Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of +7.14% and +1.27%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
  Nov 6, 2025 - $TMCI
• Treace Medical Concepts Reports Third Quarter 2025 Financial Results
  PONTE VEDRA, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today reported financial results for the third quarter ended September 30, 2025. Recent Highlights Generated revenue of $50.2 million in third quarter 2025 representing growth of 11% over the same period in 2024. Reported third quarter 2025 net
  Nov 6, 2025 - $TMCI
• Treace to Report Third Quarter 2025 Financial Results on November 6, 2025
  PONTE VEDRA, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that it will release financial results for the third quarter 2025 after the close of trading on Thursday, November 6, 2025. Company management will host a conference call to discuss financial results beginning at 4:30 pm ET. Inv
  Oct 23, 2025 - $TMCI
• Treace Medical Concepts Insider Ups Holding During Year
  From what we can see, insiders were net buyers in Treace Medical Concepts, Inc.'s ( NASDAQ:TMCI ) during the past 12...
  Sep 21, 2025 - $TMCI
• Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2025 American Orthopaedic Foot & Ankle Society Annual Meeting
  PONTE VERDE, Fla., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced it will highlight new product innovations and present new interim data for the ALIGN3D™ and MTA3D™ clinical studies at the American Orthopaedic Foot & Ankle Society (AOFAS) Annual Meeting 2025 in Savannah, Georgia from Septembe
  Sep 10, 2025 - $TMCI
• Analysts Have Been Trimming Their Treace Medical Concepts, Inc. (NASDAQ:TMCI) Price Target After Its Latest Report
  Investors in Treace Medical Concepts, Inc. ( NASDAQ:TMCI ) had a good week, as its shares rose 9.3% to close at US$6.13...
  Aug 11, 2025 - $TMCI
• Treace Medical Concepts Inc (TMCI) Q2 2025 Earnings Call Highlights: Revenue Growth and ...
  Treace Medical Concepts Inc (TMCI) reports a 7% revenue increase and significant improvements in adjusted EBITDA loss, while expanding its bunion correction portfolio.
  Aug 9, 2025 - $TMCI
• Treace Medical to Host Investor Day Highlighting New Products on September 3, 2025
  PONTE VEDRA, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced plans to host an investor day at 9:00 am E.T. on September 3, 2025, in New York, New York. The event will include presentations by members of management and experienced surgeon users, highlighting their experiences with the expa
  Aug 7, 2025 - $TMCI
• Treace Medical Concepts: Q2 Earnings Snapshot
  PONTE VEDRA, Fla. AP) — Treace Medical Concepts Inc. TMCI) on Thursday reported a loss of $17.4 million in its second quarter.
  Aug 7, 2025 - $TMCI
• Treace Medical Concepts (TMCI) Reports Q2 Loss, Beats Revenue Estimates
  Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of +3.45% and +0.79%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
  Aug 7, 2025 - $TMCI